Company Juno Therapeutics Inc
Equities
US48205A1097
Biotechnology & Medical Research
Managers
Managers | Title | Age | Since |
---|---|---|---|
Nicole Keith
IRC | Investor Relations Contact | - | 15-06-30 |
Jonathan Biller
TRE | Treasurer | 61 | - |
Corporate Secretary | 48 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 116,105,371 | 90,604,961 ( 78.04 %) | 0 | 78.04 % |
Company contact information
Juno Therapeutics, Inc.
400 Dexter Avenue North Suite 1200
98109, Seattle
+206-582-1600
http://junotherapeutics.comSector
1st Jan change | Capi. | |
---|---|---|
+15.20% | 121B | |
+19.67% | 113B | |
+18.95% | 26.02B | |
-23.86% | 19.39B | |
-19.03% | 15.91B | |
-20.90% | 15.09B | |
-46.14% | 15.06B | |
+63.85% | 14.93B | |
+4.49% | 13.85B |